JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M502814200 on May 24, 2005

J. Biol. Chem., Vol. 280, Issue 29, 27356-27365, July 22, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
280/29/27356    most recent
M502814200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Narasimhan, J.
Right arrow Articles by Kim, J.-J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Narasimhan, J.
Right arrow Articles by Kim, J.-J. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Crystal Structure of the Interferon-induced Ubiquitin-like Protein ISG15*

Jana Narasimhan{ddagger}§, Ming Wang{ddagger}§||, Zhuji Fu{ddagger}, Jennifer M. Klein**, Arthur L. Haas**{ddagger}{ddagger}, and Jung-Ja P. Kim{ddagger}§§

From the {ddagger}Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin 53226 and the **Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112

The biological effects of the ISG15 protein arise in part from its conjugation to cellular targets as a primary response to interferon-{alpha}/{beta} induction and other markers of viral or parasitic infection. Recombinant full-length ISG15 has been produced for the first time in high yield by mutating Cys78 to stabilize the protein and by cloning in a C-terminal arginine cap to protect the C terminus against proteolytic inactivation. The cap is subsequently removed with carboxypeptidase B to yield mature biologically active ISG15 capable of stoichiometric ATP-dependent thiolester formation with its human UbE1L activating enzyme. The three-dimensional structure of recombinant ISG15C78S was determined at 2.4-Å resolution. The ISG15 structure comprises two {beta}-grasp folds having main chain root mean square deviation (r.m.s.d.) values from ubiquitin of 1.7 Å (N-terminal) and 1.0 Å (C-terminal). The {beta}-grasp domains pack across two conserved 310 helices to bury 627 Å2 that accounts for 7% of the total solvent-accessible surface area. The distribution of ISG15 surface charge forms a ridge of negative charge extending nearly the full-length of the molecule. Additionally, the N-terminal domain contains an apolar region comprising almost half its solvent accessible surface. The C-terminal domain of ISG15 was superimposed on the structure of Nedd8 (r.m.s.d. = 0.84 Å) bound to its AppBp1-Uba3 activating enzyme to model ISG15 binding to UbE1L. The docking model predicts several key side-chain interactions that presumably define the specificity between the ubiquitin and ISG15 ligation pathways to maintain functional integrity of their signaling.


Received for publication, March 15, 2005 , and in revised form, May 19, 2005.

The atomic coordinates and structure factors (code 1Z2M) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

* This work was supported by U. S. Public Health Service Grants GM15977 (to J. N.), GM47426 (to A. L. H.), and GM29076 (to J.-J. P. K). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains Fig. S1.

§ Both authors contributed equally to this work.

Present address: Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202.

|| Present address: W. M. Keck Structural Biology Laboratory, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724.

{ddagger}{ddagger} To whom correspondence may be addressed: Dept. of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, 1901 Perdido St., New Orleans, LA 70112. Tel.: 504-568-3004; Fax: 504-568-3370; E-mail: ahaas{at}lsuhsc.edu.

§§ To whom correspondence may be addressed: Dept. of Biochemistry, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226. Tel.: 414-456-8479; Fax: 414-456-6510; E-mail: jjkim{at}mcw.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y.-G. Chang, X.-Z. Yan, Y.-Y. Xie, X.-C. Gao, A.-X. Song, D.-E. Zhang, and H.-Y. Hu
Different Roles for Two Ubiquitin-like Domains of ISG15 in Protein Modification
J. Biol. Chem., May 9, 2008; 283(19): 13370 - 13377.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. Serrano, M. A. Johnson, M. S. Almeida, R. Horst, T. Herrmann, J. S. Joseph, B. W. Neuman, V. Subramanian, K. S. Saikatendu, M. J. Buchmeier, et al.
Nuclear Magnetic Resonance Structure of the N-Terminal Domain of Nonstructural Protein 3 from the Severe Acute Respiratory Syndrome Coronavirus
J. Virol., November 1, 2007; 81(21): 12049 - 12060.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Herrmann, L. O. Lerman, and A. Lerman
Ubiquitin and Ubiquitin-Like Proteins in Protein Regulation
Circ. Res., May 11, 2007; 100(9): 1276 - 1291.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. J. Lenschow, C. Lai, N. Frias-Staheli, N. V. Giannakopoulos, A. Lutz, T. Wolff, A. Osiak, B. Levine, R. E. Schmidt, A. Garcia-Sastre, et al.
From the cover: IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses
PNAS, January 23, 2007; 104(4): 1371 - 1376.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. J. Y. Wong, Y. F. Pung, N. S.-K. Sze, and K.-C. Chin
HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets
PNAS, July 11, 2006; 103(28): 10735 - 10740.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
M. C. Tettamanzi, C. Yu, J. S. Bogan, and M. E. Hodsdon
Solution structure and backbone dynamics of an N-terminal ubiquitin-like domain in the GLUT4-regulating protein, TUG.
Protein Sci., March 1, 2006; 15(3): 498 - 508.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Zou and D.-E. Zhang
The Interferon-inducible Ubiquitin-protein Isopeptide Ligase (E3) EFP Also Functions as an ISG15 E3 Ligase
J. Biol. Chem., February 17, 2006; 281(7): 3989 - 3994.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. I. Kim, M. Yan, O. Malakhova, J.-K. Luo, M.-F. Shen, W. Zou, J. C. de la Torre, and D.-E. Zhang
Ube1L and Protein ISGylation Are Not Essential for Alpha/Beta Interferon Signaling
Mol. Cell. Biol., January 15, 2006; 26(2): 472 - 479.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.